Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.21 - $2.24 $15,869 - $29,377
-13,115 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.02 - $3.36 $26,492 - $44,066
13,115 New
13,115 $28,000
Q2 2021

Aug 16, 2021

SELL
$31.5 - $42.5 $364,959 - $492,405
-11,586 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$25.01 - $40.24 $289,765 - $466,220
11,586 New
11,586 $397,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.